Litigation
Nov. 12, 2015
Pharmaceutical companies prevail in diabetes drugs case
Pharmaceutical companies have prevailed in multidistrict litigation involving failure to warn of risks with diabetes drugs.
Daily Journal Staff Writer
SAN DIEGO - Pharmaceutical companies have prevailed in multidistrict litigation handled in the Southern District of California involving claims that the defendants failed to warn that four prescription drugs used to treat type 2 diabetes cause or create an increased risk of pancreatic cancer.
U.S. District Judge Anthony J. Battaglia on Monday granted summary judgment for the pharmaceutical compan...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In